UPDATE: UBS Securities Downgrades Patterson Companies to Neutral, Reiterates $46 PT on F2Q14 Preview and Valuation Update

Loading...
Loading...
In a report published Wednesday, UBS Securities analyst Steven Valiquette downgraded the rating on
Patterson CompaniesPDCO
from Buy to Neutral, but reiterated the $46.00 price target. In the report, UBS Securities noted, “Based on strong U.S. trends from dental/vet peers, and a much easier dental equip comp, we are comfortable with our $0.49 EPS view vs. Street's $0.48 for PDCO's F2Q14 results to be reported Thurs a.m. (11/21). However, the dental equip comps get much tougher in the back half of FY14, and with pressure on the P&L related to voluntary I/T investments this year, it seems the run-up in the stock (up 26% YTD) has now priced in most of the good news related to U.S. dental trends. With stock now at P/E of 18x on CY14E, and 10x EBITDA, we downgrade to Neutral.” Patterson Companies closed on Tuesday at $42.88.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesAnalyst RatingsSteven ValiquetteUBS Securities
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...